Enjoy complimentary customisation on priority with our Enterprise License!
The companion diagnostics market size is forecast to increase by USD 28.98 billion, at a CAGR of 36.5% between 2023 and 2028. The companion diagnostics market is experiencing significant growth due to the rising adoption of personalized medicine. This approach to healthcare identifies and treats diseases based on an individual's unique genetic makeup, necessitating precise diagnostic tools. Industry collaborations are increasingly common, with pharmaceutical companies partnering with diagnostic solution providers to develop and commercialize companion diagnostics. Furthermore, the life sciences sector is witnessing substantial investments, fueled by the potential of these advanced diagnostic solutions to improve patient outcomes and reduce healthcare costs. The companion diagnostics market is poised for expansion, driven by these trends and the increasing demand for personalized healthcare solutions.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Indication
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.